Development of a novel nomogram for predicting clinically significant prostate cancer with the prostate health index and multiparametric MRI
IntroductionOn prostate biopsy, multiparametric magnetic resonance imaging (mpMRI) and the Prostate Health Index (PHI) have allowed prediction of clinically significant prostate cancer (csPCa).MethodsTo predict the likelihood of csPCa, we created a nomogram based on a multivariate model that include...
Main Authors: | Li-Cai Mo, Xian-Jun Zhang, Hai-Hong Zheng, Xiao-peng Huang, Lin Zheng, Zhi-Rui Zhou, Jia-Jia Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1068893/full |
Similar Items
-
Could Biparametric MRI Replace Multiparametric MRI in the Management of Prostate Cancer?
by: Roxana Iacob, et al.
Published: (2023-02-01) -
Multiparametric MRI Fusion-Guided Prostate Biopsy for Detection of Clinically Significant Prostate Cancer Eliminates the Systemic Prostate Biopsy
by: Augustinas Matulevičius, et al.
Published: (2022-10-01) -
Accuracy of pelvic multiparametric MRI in diagnosing local recurrence following radical prostatectomy. Case report and revision of the literature
by: Pietro Pepe, et al.
Published: (2016-01-01) -
Prediction of Clinically Significant Cancer Using Radiomics Features of Pre-Biopsy of Multiparametric MRI in Men Suspected of Prostate Cancer
by: Chidozie N. Ogbonnaya, et al.
Published: (2021-12-01) -
Real-Time MRI-Guided Prostate Interventions
by: Seyedeh Nina Masoom, et al.
Published: (2022-04-01)